Trials / Completed
CompletedNCT04500743
Role of Suppression of Endometriosis With Progestins Before IVF-ET
Role of Suppression of Endometriosis With Progestins Before IVF-ET: a Non-inferiority Randomized Controlled Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 134 (actual)
- Sponsor
- National Research Centre, Egypt · Academic / Other
- Sex
- Female
- Age
- 30 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
This study aimed to assess the role of Dienogest pretreatment for endometriosis suppression as compared to Gonadotropin-releasing hormone agonist (GnRHa) in patients with endometriosis pursuing IVF treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Dienogest | Group B (n=67) who had daily oral Dienogest 2 mg/d for 3 months before starting standard long protocol for IVF |
| DRUG | leuprorelin acetate | Group A (n=67) who had monthly depot GnRHa for 3 months before ovarian stimulation in IVF treatment (Ultra-long protocol) |
Timeline
- Start date
- 2018-08-01
- Primary completion
- 2019-10-31
- Completion
- 2020-04-30
- First posted
- 2020-08-05
- Last updated
- 2020-08-05
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT04500743. Inclusion in this directory is not an endorsement.